Search results
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b...
Morningstar· 7 days agoVeru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
5 Stocks Powering the Dow ETF Year to Date
Zacks via Yahoo Finance· 5 days agoThe Dow Jones touched the milestone of 40,000 for the first time on strong corporate earnings and renewed bets for rate cuts. We have highlighted five...
Nano Drug Accelerates Diabetic Wound Healing in Mi | Newswise
Newswise· 6 days agoResearchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair. Using tiny fat
As the DIA ETF hits a record high, here are its best stocks in 2024 | Invezz
Invezz· 5 days agoThe SPDR Dow Jones Industrial Average (DIA) ETF continued its remarkable bull run this year. The DIA...